Chimerism does not predict for outcome after alemtuzumab based conditioning.
Michaelis L, Lin S, Joseph L, Artz AS, Kline J, Pollyea D, Stock W, Rich E, Collins-Jones D, Casey B, Del Cerro P, van Besien K.
Michaelis L, et al.
Bone Marrow Transplant. 2007 Jul;40(2):181. doi: 10.1038/sj.bmt.1705707. Epub 2007 May 14.
Bone Marrow Transplant. 2007.
PMID: 17502895
No abstract available.